Healthcare

Tivity Atty’s ‘Suspicious Stock Sales’ Support Suit, Judge Says

Fitness and wellness program provider Tivity Health lost a bid to kill a stock-drop suit on Monday when a Tennessee federal judge said allegations of “suspicious stock sales” by executives, including Tivity’s chief legal officer, bolstered the case against the company…

Read this piece in its entirety at Law360.

 

Pharma Co. Pumped Stock By Hiding Drug Failures, Suit Says

A proposed class of investors hit Corbus Pharmaceutical Holdings Inc. and two of its top executives with a securities suit in Massachusetts federal court Tuesday alleging that the company and its officers concealed negative results in clinical trials of its flagship drug…

Read this piece in its entirety at Law360.

Hospira Tells Fed. Circ. To Reverse Sedative Patent Loss

Hospira Inc. asked the Federal Circuit on Tuesday to uphold the validity of a patent for its sedation drug Precedex for the second time this year, arguing that an Illinois federal court hadn’t correctly analyzed the obviousness of a key claim when deciding to invalidate the patent…

Read this piece in its entirety at Law360.

‘Absurd’ To Argue PTAB Wins Bar Patent Cases: Generics Cos.

The America Invents Act doesn’t stop patent challengers who won at the Patent Trial and Appeal Board from pursuing their winning arguments in court, and blocking that judicial path would lead to “absurd results,” a group of generic-drug makers told the Federal Circuit on Tuesday…

Read this piece in its entirety at Law360.

Indivior Wins Temporary Block On Alvogen Suboxone Generic

Indivior Inc. on Thursday won a bid to temporarily block New Jersey-based Alvogen Pine Brook Inc. from selling a generic version of the opioid addiction treatment drug Suboxone, which is at the center of an ongoing patent row, according to an order from a Garden State federal judge…

Read this piece in its entirety at Law360.